Cas:218278-62-7 3-Amino-5-phenylpentanoic acid manufacturer & supplier

We serve Chemical Name:3-Amino-5-phenylpentanoic acid CAS:218278-62-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Amino-5-phenylpentanoic acid

Chemical Name:3-Amino-5-phenylpentanoic acid
CAS.NO:218278-62-7
Synonyms:(3S)-3-Amino-5-phenylpentanoic acid;3-Amino-5-phenyl-pentanoic acid;3-Amino-5-phenylpentanoic acid;Benzenepentanoic acid, β-amino-, (βS)-;Benzenepentanoic acid, β-amino-
Molecular Formula:C11H15NO2
Molecular Weight:193.242
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:368.2±42.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.556
PSA:63.32000
Exact Mass:193.110275
LogP:1.45

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (3S)-3-Amino-5-phenylpentanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenepentanoic acid, β-amino- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Amino-5-phenylpentanoic acid Use and application,3-Amino-5-phenylpentanoic acid technical grade,usp/ep/jp grade.


Related News: The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. 3-Amino-5-phenylpentanoic acid manufacturer Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. 3-Amino-5-phenylpentanoic acid supplier The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. 3-Amino-5-phenylpentanoic acid vendor A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. 3-Amino-5-phenylpentanoic acid factory Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant.